← Back to Leadership
President and CEO
President and CEO of FORUS Therapeutics Inc, Kevin and the team are building a unique, Canadian Specialty Pharmaceutical company; the priority being to identify, develop and commercialize important novel medicines for Canadians living with cancer.
Building on his industry experience, including significant and progressive roles within Pfizer and Roche Canada, Kevin joined Celgene Corporation in 2006 to establish Celgene Canada. Over the next 13 years, under Kevin’s leadership, Celgene grew rapidly, successfully launching important products for patients living with cancer and building an industry leading team of hematology oncology professionals.
Throughout his 25 year career, he has been an outspoken and passionate champion for the Canadian Life Sciences Industry, holding significant industry leadership roles including Treasurer and Executive Board member with BioteCanada.